메뉴 건너뛰기




Volumn 32, Issue 12, 2003, Pages 1104-1109

Therapy for postmenopausal osteoporosis;Therapie der postmenopausalen osteoporoses

(1)  Keck, E a  

a NONE   (Germany)

Author keywords

Bisphosphonates; Calcium; Estrogens gestagens; Fluorides; High and low turnover; Parathyroid hormone; Postmenopausal osteoporosis; Raloxifene; Vitamin D

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; COLLAGEN TYPE 1; ESTROGEN; ETIDRONIC ACID; FLUORIDE; GESTAGEN; PARATHYROID HORMONE; RALOXIFENE; RISEDRONIC ACID; TAMOXIFEN; VITAMIN D; ANTIESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

EID: 0348010460     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-003-0561-8     Document Type: Review
Times cited : (1)

References (8)
  • 1
    • 0033305354 scopus 로고    scopus 로고
    • Monofluorphosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: A Randomized Study
    • Alexandersen P (1999) Monofluorphosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: A Randomized Study. J Clin Endocrinol Metabol 84: 3013-3020
    • (1999) J Clin Endocrinol Metabol , vol.84 , pp. 3013-3020
    • Alexandersen, P.1
  • 2
    • 0347705930 scopus 로고    scopus 로고
    • Therapie der primären Osteoporose des Mannes
    • im Druck
    • Beckmann G, Keck E (2003) Therapie der primären Osteoporose des Mannes. Osteologie (im Druck)
    • (2003) Osteologie
    • Beckmann, G.1    Keck, E.2
  • 3
    • 0347075416 scopus 로고    scopus 로고
    • Pathologisch orientiertes Therapiekonzept bei Osteoporosen
    • Keck E (1997) Pathologisch orientiertes Therapiekonzept bei Osteoporosen. Osteologie 6: 30-37
    • (1997) Osteologie , vol.6 , pp. 30-37
    • Keck, E.1
  • 4
    • 0030804947 scopus 로고    scopus 로고
    • Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
    • Lindsay R (1997) Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350: 550-555
    • (1997) Lancet , vol.350 , pp. 550-555
    • Lindsay, R.1
  • 5
    • 0035837553 scopus 로고    scopus 로고
    • Effect of parathyroid hormone on fractures and bone mineral densitiy in postmenopausal women with osteoporosis
    • Neer RM (2001) Effect of parathyroid hormone on fractures and bone mineral densitiy in postmenopausal women with osteoporosis. New Engl J Med 344: 1434-1441
    • (2001) New Engl J Med , vol.344 , pp. 1434-1441
    • Neer, R.M.1
  • 6
    • 0024531988 scopus 로고
    • Safe and effective treatment of osteoporosis with intermittend slow-release sodium fluoride: Augmentation of vertebral bone mass and inhibition of fractures
    • Pak CYC (1989) Safe and effective treatment of osteoporosis with intermittend slow-release sodium fluoride: Augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metabol 68: 150-159
    • (1989) J Clin Endocrinol Metabol , vol.68 , pp. 150-159
    • Pak, C.Y.C.1
  • 7
    • 0002889563 scopus 로고    scopus 로고
    • Prävention und Therapie der Osteoporose: Die Bedeutung des Sports und der körperlichen Aktivität
    • Platen P (1997) Prävention und Therapie der Osteoporose: Die Bedeutung des Sports und der körperlichen Aktivität. Dtsch Ärztebl A 94: 2569-2574
    • (1997) Dtsch Ärztebl A , vol.94 , pp. 2569-2574
    • Platen, P.1
  • 8
    • 0037703447 scopus 로고    scopus 로고
    • Die DVO-Leitlinien zur Osteoporose
    • Scheidt-Nave C (2003) Die DVO-Leitlinien zur Osteoporose. Osteologie 12: 63-91
    • (2003) Osteologie , vol.12 , pp. 63-91
    • Scheidt-Nave, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.